Fulcrum Therapeutics Names Isabel Kalofonos as Chief Commercial Officer, Heather Faulds as Chief Regulatory Affairs Officer

MT Newswires Live08-19

Fulcrum Therapeutics (FULC) said Monday it has appointed Isabel Kalofonos as chief commercial officer.

Kalofonos previously served as chief commercial officer at ImmunoGen (IMGN).

Meanwhile, Heather Faulds was named chief regulatory affairs and quality assurance officer. Faulds previously served as SVP of regulatory affairs at Alkermes.

Price: 9.15, Change: -0.09, Percent Change: -0.97

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment